BPH Energy Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
345.00
0.10
0.10
0.00
-
Gross Income
345.00
0.10
0.10
0.00
-
SG&A Expense
451.40
639.90
518.50
764.50
702.60
EBIT
796.50
1,724.30
518.60
768.50
702.60
Unusual Expense
737.00
27,959.80
-
11.10
-
Non Operating Income/Expense
114.10
10.90
12.80
6.70
6.60
Interest Expense
-
-
-
2.20
1.80
Pretax Income
1,267.80
29,470.70
349.70
584.80
1,478.30
Income Tax
314.60
3,583.30
-
-
-
Equity in Affiliates
312.90
603.10
161.80
87.70
28.50
Consolidated Net Income
1,266.10
26,490.50
511.40
672.50
1,506.80
Net Income
1,253.60
26,487.70
509.50
636.90
1,505.80
Net Income After Extraordinaries
1,253.60
26,487.70
509.50
636.90
1,505.80
Net Income Available to Common
1,253.60
26,487.70
509.50
636.90
1,505.80
EPS (Basic)
0.01
0.11
0.00
0.00
0.00
Basic Shares Outstanding
172,562.20
234,167.10
235,766.70
426,024.40
742,486.40
EPS (Diluted)
0.01
0.11
0.00
0.00
0.00
Diluted Shares Outstanding
172,562.20
234,167.10
235,766.70
426,024.40
742,486.40
EBITDA
796.20
1,724.20
518.50
768.50
702.60
Other Operating Expense
-
1,084.40
-
4.00
-
Non-Operating Interest Income
151.60
224.40
181.80
203.80
235.80
Minority Interest Expense
12.50
2.80
2.00
35.70
0.90

About BPH Energy

View Profile
Address
14 View Street
North Perth Western Australia (WA) 6006
Australia
Employees -
Website http://www.bphenergy.com.au
Updated 07/08/2019
BPH Energy Ltd. engages in the development of biomedical research and technologies within universities and hospital institutes. The firm provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise. Its investments include molecular discovery systems, HLS5 Project, cortical dynamics, diagnostic array systems, and Advent Energy Limited.